List of Tables
Table 1. Global Liver Transplant Anti-Rejection Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Liver Transplant Anti-Rejection Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Liver Transplant Anti-Rejection Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Liver Transplant Anti-Rejection Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Liver Transplant Anti-Rejection Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Liver Transplant Anti-Rejection Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Liver Transplant Anti-Rejection Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Liver Transplant Anti-Rejection Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Liver Transplant Anti-Rejection Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Liver Transplant Anti-Rejection Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Liver Transplant Anti-Rejection Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Liver Transplant Anti-Rejection Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Transplant Anti-Rejection Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Liver Transplant Anti-Rejection Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Liver Transplant Anti-Rejection Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Liver Transplant Anti-Rejection Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Liver Transplant Anti-Rejection Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Liver Transplant Anti-Rejection Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Liver Transplant Anti-Rejection Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Liver Transplant Anti-Rejection Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Liver Transplant Anti-Rejection Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Liver Transplant Anti-Rejection Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Liver Transplant Anti-Rejection Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Liver Transplant Anti-Rejection Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Liver Transplant Anti-Rejection Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Liver Transplant Anti-Rejection Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Liver Transplant Anti-Rejection Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Liver Transplant Anti-Rejection Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Liver Transplant Anti-Rejection Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Liver Transplant Anti-Rejection Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Liver Transplant Anti-Rejection Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Liver Transplant Anti-Rejection Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Liver Transplant Anti-Rejection Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Liver Transplant Anti-Rejection Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Liver Transplant Anti-Rejection Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Liver Transplant Anti-Rejection Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Liver Transplant Anti-Rejection Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Liver Transplant Anti-Rejection Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Liver Transplant Anti-Rejection Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Liver Transplant Anti-Rejection Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Liver Transplant Anti-Rejection Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Liver Transplant Anti-Rejection Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Liver Transplant Anti-Rejection Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Liver Transplant Anti-Rejection Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Liver Transplant Anti-Rejection Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Liver Transplant Anti-Rejection Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Liver Transplant Anti-Rejection Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Liver Transplant Anti-Rejection Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Liver Transplant Anti-Rejection Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Liver Transplant Anti-Rejection Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Liver Transplant Anti-Rejection Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Liver Transplant Anti-Rejection Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Liver Transplant Anti-Rejection Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Liver Transplant Anti-Rejection Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Liver Transplant Anti-Rejection Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Liver Transplant Anti-Rejection Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Liver Transplant Anti-Rejection Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Liver Transplant Anti-Rejection Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Liver Transplant Anti-Rejection Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Liver Transplant Anti-Rejection Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Liver Transplant Anti-Rejection Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Roche Corporation Information
Table 71. Roche Description and Business Overview
Table 72. Roche Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Roche Liver Transplant Anti-Rejection Drugs Product
Table 74. Roche Recent Developments/Updates
Table 75. Astellas Pharma Inc. Corporation Information
Table 76. Astellas Pharma Inc. Description and Business Overview
Table 77. Astellas Pharma Inc. Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Astellas Pharma Inc. Liver Transplant Anti-Rejection Drugs Product
Table 79. Astellas Pharma Inc. Recent Developments/Updates
Table 80. Sanofi Genzyme Corporation Information
Table 81. Sanofi Genzyme Description and Business Overview
Table 82. Sanofi Genzyme Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Sanofi Genzyme Liver Transplant Anti-Rejection Drugs Product
Table 84. Sanofi Genzyme Recent Developments/Updates
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Novartis Liver Transplant Anti-Rejection Drugs Product
Table 89. Novartis Recent Developments/Updates
Table 90. Asahi Kasei Corporation(Veloxis Pharmaceuticals) Corporation Information
Table 91. Asahi Kasei Corporation(Veloxis Pharmaceuticals) Description and Business Overview
Table 92. Asahi Kasei Corporation(Veloxis Pharmaceuticals) Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Asahi Kasei Corporation(Veloxis Pharmaceuticals) Liver Transplant Anti-Rejection Drugs Product
Table 94. Asahi Kasei Corporation(Veloxis Pharmaceuticals) Recent Developments/Updates
Table 95. Wyeth Corporation Information
Table 96. Wyeth Description and Business Overview
Table 97. Wyeth Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Wyeth Liver Transplant Anti-Rejection Drugs Product
Table 99. Wyeth Recent Developments/Updates
Table 100. Bristol-Myers Squibb Company Corporation Information
Table 101. Bristol-Myers Squibb Company Description and Business Overview
Table 102. Bristol-Myers Squibb Company Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Bristol-Myers Squibb Company Liver Transplant Anti-Rejection Drugs Product
Table 104. Bristol-Myers Squibb Company Recent Developments/Updates
Table 105. Nippon Kayaku Corporation Information
Table 106. Nippon Kayaku Description and Business Overview
Table 107. Nippon Kayaku Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Nippon Kayaku Liver Transplant Anti-Rejection Drugs Product
Table 109. Nippon Kayaku Recent Developments/Updates
Table 110. Hansa Biopharma Corporation Information
Table 111. Hansa Biopharma Description and Business Overview
Table 112. Hansa Biopharma Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Hansa Biopharma Liver Transplant Anti-Rejection Drugs Product
Table 114. Hansa Biopharma Recent Developments/Updates
Table 115. GSK Corporation Information
Table 116. GSK Description and Business Overview
Table 117. GSK Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. GSK Liver Transplant Anti-Rejection Drugs Product
Table 119. GSK Recent Developments/Updates
Table 120. AbbVie Corporation Information
Table 121. AbbVie Description and Business Overview
Table 122. AbbVie Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. AbbVie Liver Transplant Anti-Rejection Drugs Product
Table 124. AbbVie Recent Developments/Updates
Table 125. Huadong Medicine Corporation Information
Table 126. Huadong Medicine Description and Business Overview
Table 127. Huadong Medicine Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Huadong Medicine Liver Transplant Anti-Rejection Drugs Product
Table 129. Huadong Medicine Recent Developments/Updates
Table 130. North China Pharmaceutical Group Corporation Information
Table 131. North China Pharmaceutical Group Description and Business Overview
Table 132. North China Pharmaceutical Group Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. North China Pharmaceutical Group Liver Transplant Anti-Rejection Drugs Product
Table 134. North China Pharmaceutical Group Recent Developments/Updates
Table 135. Beijing SL Pharmaceutical Corporation Information
Table 136. Beijing SL Pharmaceutical Description and Business Overview
Table 137. Beijing SL Pharmaceutical Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Beijing SL Pharmaceutical Liver Transplant Anti-Rejection Drugs Product
Table 139. Beijing SL Pharmaceutical Recent Developments/Updates
Table 140. Livzon Pharm Corporation Information
Table 141. Livzon Pharm Description and Business Overview
Table 142. Livzon Pharm Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Livzon Pharm Liver Transplant Anti-Rejection Drugs Product
Table 144. Livzon Pharm Recent Developments/Updates
Table 145. Ruibang Pharmaceutical Corporation Information
Table 146. Ruibang Pharmaceutical Description and Business Overview
Table 147. Ruibang Pharmaceutical Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Ruibang Pharmaceutical Liver Transplant Anti-Rejection Drugs Product
Table 149. Ruibang Pharmaceutical Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Liver Transplant Anti-Rejection Drugs Distributors List
Table 153. Liver Transplant Anti-Rejection Drugs Customers List
Table 154. Liver Transplant Anti-Rejection Drugs Market Trends
Table 155. Liver Transplant Anti-Rejection Drugs Market Drivers
Table 156. Liver Transplant Anti-Rejection Drugs Market Challenges
Table 157. Liver Transplant Anti-Rejection Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Liver Transplant Anti-Rejection Drugs
Figure 2. Global Liver Transplant Anti-Rejection Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Liver Transplant Anti-Rejection Drugs Market Share by Type in 2023 & 2030
Figure 4. Glucocorticoids Product Picture
Figure 5. Anti-Proliferative Drugs Product Picture
Figure 6. T Cell Mediated Immunosuppressants Product Picture
Figure 7. Global Liver Transplant Anti-Rejection Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Liver Transplant Anti-Rejection Drugs Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Pharmacy
Figure 11. Online Sales
Figure 12. Medical Institutions
Figure 13. Global Liver Transplant Anti-Rejection Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Liver Transplant Anti-Rejection Drugs Market Size (2019-2030) & (US$ Million)
Figure 15. Global Liver Transplant Anti-Rejection Drugs Sales (2019-2030) & (K Units)
Figure 16. Global Liver Transplant Anti-Rejection Drugs Average Price (US$/Unit) & (2019-2030)
Figure 17. Liver Transplant Anti-Rejection Drugs Report Years Considered
Figure 18. Liver Transplant Anti-Rejection Drugs Sales Share by Manufacturers in 2023
Figure 19. Global Liver Transplant Anti-Rejection Drugs Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Liver Transplant Anti-Rejection Drugs Players: Market Share by Revenue in 2023
Figure 21. Liver Transplant Anti-Rejection Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Liver Transplant Anti-Rejection Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Liver Transplant Anti-Rejection Drugs Sales Market Share by Country (2019-2030)
Figure 24. North America Liver Transplant Anti-Rejection Drugs Revenue Market Share by Country (2019-2030)
Figure 25. United States Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Liver Transplant Anti-Rejection Drugs Sales Market Share by Country (2019-2030)
Figure 28. Europe Liver Transplant Anti-Rejection Drugs Revenue Market Share by Country (2019-2030)
Figure 29. Germany Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Liver Transplant Anti-Rejection Drugs Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Liver Transplant Anti-Rejection Drugs Revenue Market Share by Region (2019-2030)
Figure 36. China Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Liver Transplant Anti-Rejection Drugs Sales Market Share by Country (2019-2030)
Figure 44. Latin America Liver Transplant Anti-Rejection Drugs Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Liver Transplant Anti-Rejection Drugs Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Liver Transplant Anti-Rejection Drugs Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Liver Transplant Anti-Rejection Drugs by Type (2019-2030)
Figure 54. Global Revenue Market Share of Liver Transplant Anti-Rejection Drugs by Type (2019-2030)
Figure 55. Global Liver Transplant Anti-Rejection Drugs Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Liver Transplant Anti-Rejection Drugs by Application (2019-2030)
Figure 57. Global Revenue Market Share of Liver Transplant Anti-Rejection Drugs by Application (2019-2030)
Figure 58. Global Liver Transplant Anti-Rejection Drugs Price (US$/Unit) by Application (2019-2030)
Figure 59. Liver Transplant Anti-Rejection Drugs Value Chain
Figure 60. Liver Transplant Anti-Rejection Drugs Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
